• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    178.86 Down 0.96(0.53%) Aug 28, 4:00PM EDT
    |After Hours : 178.86 0.00 (0.00%) Aug 28, 4:57PM EDT
    Add to Portfolio
    Prev Close:179.82
    Open:178.40
    Bid:177.20 x 300
    Ask:186.71 x 1000
    1y Target Est:225.61
    Beta:1.20622
    Earnings Date:Oct 21 - Oct 26 (Est.)
    Day's Range:176.32 - 180.00
    52wk Range:150.06 - 208.88
    Volume:1,477,803
    Avg Vol (3m):1,833,100
    Market Cap:40.45B
    P/E (ttm):61.09
    EPS (ttm):2.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 0.53%40.45B
    AMGNUp 0.11%118.20B
    BAXUp 0.41%21.14B

    Key Statistics

    Forward P/E (1 yr):29.96
    P/S (ttm):17.01
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.84
    Quarterly EPS Est (Sep-15) :1.01
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):2.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback